The m6A reader protein IGF2BP1 could activate SRF-dependent transcription and thus endorse tumor cell growth in an m6A-dependent manner in ovarian, liver, and lung cancers (Muller et al., 2019). Here, IGF2BP1 is linked to neoplasm.